India Rewrites the Rulebook for Stem Cell Therapies and Essential Drug Pricing in Landmark Healthcare Reform
New regulatory framework brings gene and cell therapies under formal oversight while controversial pricing changes could reshape access to essential medicines
Can Rheumatoid Arthritis Be Stopped Before It Starts? Landmark Trial Shows 60% Prevention Success
A groundbreaking UK study demonstrates that early intervention with an existing drug can prevent the onset of debilitating autoimmune disease in high-risk patients, opening the door for AI-powered predictive screening.
Million-Heart Dataset Deal Positions Australian Startup at Forefront of AI Cardiac Diagnostics Race
EchoIQ's exclusive access to up to one million echocardiogram scans represents one of the largest cardiovascular imaging datasets secured for AI development in the Asia-Pacific region.
The Circadian Surgery Revolution: Why Your Heart Operation Time Might Matter as Much as Your Surgeon
Afternoon cardiac surgeries show significantly less heart muscle damage than morning procedures, as researchers discover our internal biological clocks may influence how patients respond to operations.
Why the FDA Is Betting on Biology-Driven AI to Fix Drug Development's $2 Billion Failure Problem
Mechanistic AI that explains *why* drugs work—rather than just predicting outcomes—could finally give regulators the transparency needed to accelerate drug development and reduce catastrophic trial failures.
The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Why Drug Trials Are About to Get Smarter: FDA Embraces Statistical Revolution That Could Save Years of Research
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
When Your Parent Refuses Assisted Living, Silicon Valley Steps In With 24/7 Surveillance
AI-powered monitoring systems promise to help seniors age safely at home, but raise critical questions about privacy, autonomy, and the ethics of constant surveillance.
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.